Patents by Inventor Elena GROSS

Elena GROSS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890264
    Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: February 6, 2024
    Assignee: UNIVERSITATS-KINDERSPITAL BEIDER BASEL
    Inventors: Elena Gross, Dirk Fischer
  • Publication number: 20220257546
    Abstract: The invention relates to a composition comprising ketone bodies contained in microbeads, in particular, for use in maintaining an increased blood concentration of ketone bodies in a subject for a prolonged period of time, preferably for the use as a medicament, food for special medical purposes/medical food or nutraceutical/food supplement. It further relates to methods to produce a composition comprising ketone bodies contained in microbeads. Also provided are non-medical uses of microbeads/ketone bodies/compositions of the invention.
    Type: Application
    Filed: May 8, 2020
    Publication date: August 18, 2022
    Inventors: Elena GROSS, Sinead Brigid BLEIEL
  • Patent number: 11166928
    Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: November 9, 2021
    Inventors: Elena Gross, Dirk Fischer
  • Publication number: 20210338618
    Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 1, 2021
    Publication date: November 4, 2021
    Inventors: Elena GROSS, Dirk FISCHER
  • Publication number: 20190374490
    Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanediol and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 20, 2017
    Publication date: December 12, 2019
    Inventors: Elena GROSS, Dirk FISCHER